NO940778D0 - Mutant growth factor receptor as a drug and its use to treat cancer - Google Patents

Mutant growth factor receptor as a drug and its use to treat cancer

Info

Publication number
NO940778D0
NO940778D0 NO940778A NO940778A NO940778D0 NO 940778 D0 NO940778 D0 NO 940778D0 NO 940778 A NO940778 A NO 940778A NO 940778 A NO940778 A NO 940778A NO 940778 D0 NO940778 D0 NO 940778D0
Authority
NO
Norway
Prior art keywords
drug
growth factor
factor receptor
treat cancer
mutant growth
Prior art date
Application number
NO940778A
Other languages
Norwegian (no)
Other versions
NO940778L (en
Inventor
Norbert Redemann
Axel Ulrich
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of NO940778D0 publication Critical patent/NO940778D0/en
Publication of NO940778L publication Critical patent/NO940778L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO940778A 1991-09-05 1994-03-04 Mutant growth factor receptor as a drug and its use to treat cancer NO940778L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19914129533 DE4129533A1 (en) 1991-09-05 1991-09-05 MUTTED GROWTH FACTOR RECEPTOR AS A MEDICINAL PRODUCT AND ITS USE FOR TREATING CANCER
PCT/EP1992/002058 WO1993005148A1 (en) 1991-09-05 1992-09-07 Mutated growth factor receptor as medicament and its use for treating cancer

Publications (2)

Publication Number Publication Date
NO940778D0 true NO940778D0 (en) 1994-03-04
NO940778L NO940778L (en) 1994-05-04

Family

ID=6439926

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940778A NO940778L (en) 1991-09-05 1994-03-04 Mutant growth factor receptor as a drug and its use to treat cancer

Country Status (12)

Country Link
EP (1) EP0667899A1 (en)
JP (1) JPH07502884A (en)
CN (1) CN1071586A (en)
AU (1) AU669857B2 (en)
CA (1) CA2117073A1 (en)
DE (1) DE4129533A1 (en)
FI (1) FI941053A (en)
MX (1) MX9205084A (en)
NO (1) NO940778L (en)
NZ (1) NZ244239A (en)
PT (1) PT100844A (en)
WO (1) WO1993005148A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN274295A0 (en) * 1995-05-02 1995-05-25 Garvan Institute Of Medical Research GDU, a novel signalling protein
US6465623B2 (en) 1995-05-02 2002-10-15 Garvan Institute Of Medical Research GDU, a novel signalling protein
US6790614B1 (en) 1999-11-19 2004-09-14 Novartis Ag Selectable cell surface marker genes
CN104480200B (en) 2004-03-31 2017-12-29 综合医院公司 Determine method of the cancer to EGF-R ELISA magnetic target therapy reactivity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0325224B1 (en) * 1988-01-22 1996-07-31 ZymoGenetics, Inc. Methods of producing secreted receptor analogs
WO1990008160A1 (en) * 1989-01-20 1990-07-26 Imperial Cancer Research Technology Ltd. Growth factor receptor-like peptides without tyrosine-kinase activity
GB9001466D0 (en) * 1990-01-23 1990-03-21 Erba Carlo Spa Extracellular form of the human fibroblast growth factor receptor
CA2055441C (en) * 1989-05-19 2003-01-07 Robert M. Hudziak Her2 extracellular domain
JP2975679B2 (en) * 1989-09-08 1999-11-10 ザ・ジョーンズ・ホプキンス・ユニバーシティ Structural change of EGF receptor gene in human glioma

Also Published As

Publication number Publication date
DE4129533A1 (en) 1993-03-11
AU2518592A (en) 1993-04-05
CN1071586A (en) 1993-05-05
MX9205084A (en) 1993-05-01
FI941053A (en) 1994-04-08
EP0667899A1 (en) 1995-08-23
FI941053A0 (en) 1994-03-04
NZ244239A (en) 1995-07-26
JPH07502884A (en) 1995-03-30
NO940778L (en) 1994-05-04
WO1993005148A1 (en) 1993-03-18
AU669857B2 (en) 1996-06-27
CA2117073A1 (en) 1993-03-18
PT100844A (en) 1994-05-31

Similar Documents

Publication Publication Date Title
NO924768D0 (en) PHARMACEUTICAL PREPARATION AND PROCEDURE FOR ITS PREPARATION
ATA129892A (en) PHARMACEUTICAL COMPOSITION
NO940210D0 (en) Close for drug burn
LV10386A (en) Pharmaceutical composition and preparation for its preparation
NO891006D0 (en) THERAPEUTIC ACTIVE POLYPEPTID AND PROCEDURE FOR ITS PREPARATION.
AU1858992A (en) 2-(1-piperidyl)ethanol derivatives, their preparation and their therapeutic application
NO940778D0 (en) Mutant growth factor receptor as a drug and its use to treat cancer
DE69205502D1 (en) Stick composition containing hydrochloric acid sodium and stearyl alcohol.
DK43489A (en) IMMUNOTOXIN AND PROCEDURE FOR ITS PREPARATION
DK73091D0 (en) QUINOXAL COMPOUNDS, THEIR PREPARATION AND USE
NO921834L (en) PAIN REGULATORY COMPOSITION AND PROCEDURE FOR MANUFACTURING
AU2299592A (en) Treatment of periodontal disease with protease inhibitors
NO934227D0 (en) Pyrrole derivatives, methods for their preparation and therapeutic use
NO179073C (en) Imide-terminated polynitrogen compounds, their preparation and use
ITMI912426A1 (en) 6-AMINOKINOLONES, SYNTHESIS AND USE AS ANTIBACTERIALS
KR930012948U (en) Swivel bed
GB2260493B (en) Device to administer actives over extended periods
ES1018520Y (en) THERAPEUTIC PILLOW.
ZA924789B (en) 2-(1-piperidyl)ethanol derivatives,their preparation and their therapeutic application
FI980391A0 (en) Polyhydroxycyclopentane derivatives, their preparation and therapeutic use
IT8809003A0 (en) THERAPEUTIC SUPPORT FOR LONG-TERM PEOPLE
DE69223962D1 (en) CHAIR MECHANISM
ITAN910030U1 (en) -UNIVERSAL HEADBOARD FOR SINGLE AND DOUBLE BEDS
NO920063D0 (en) PHARMACEUTICAL PREPARATION AND ITS USE
ES1018236Y (en) IMPROVED THERAPEUTIC BRACELET.